Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
BPC-157 has demonstrated protective effects against NSAID-induced gastric damage in research, but whether this translates to clinical interaction effects remains unclear
Jak gramy
Researchers first studied it for its protective effects on the stomach lining and digestive tract, where it showed promise for ulcers, inflammatory bowel disease, and other gut-related conditions
Physicians prescribe it primarily for iron deficiency anemia (IDA) in patients who cannot absorb adequate oral iron, and for patients with chronic kidney disease (CKD) on hemodialysis who require iron supplementation to support erythropoiesis-stimulating agent (ESA) therapy, such as epoetin biosimilars billed under HCPCS code Q5105
